Bao Yige, Tu Xiang, Wei Qiang
West China Hospital, Sichuan University, Department of Urology, No. 37, Guo Xue Xiang, Chengdu, Sichuan, China, 610041.
Sichuan University, West China School of Clinical Medicine, Chengdu, China.
Cochrane Database Syst Rev. 2020 Feb 11;2(2):CD004292. doi: 10.1002/14651858.CD004292.pub4.
Urinary stone disease is a common condition characterised by increasing prevalence and high rates of recurrence. Observational studies have reported that increased water intake played a role in the prevention of urinary stone formation but with limited strength of evidence.
To compare the effects of increased water intake with standard water intake for the prevention of urinary stone formation in participants with or without a history of urinary stones.
We performed a systematic search of PubMed (MEDLINE), EMBASE (Ovid) and the Cochrane Library to 15 October 2019. We handsearched review articles, clinical trial registries, and reference lists of retrieved articles. We did not apply any restrictions to publication language or publication status.
We included randomised controlled trials (RCTs) and quasi-RCTs looking at the benefits and harms of increased water intake versus standard water intake for the prevention of urinary stone formation in participants with or without a history of urinary stones.
We used standard methodological procedures expected by Cochrane. Two review authors independently extracted data and assessed the risk of bias of included studies. We pooled dichotomous outcomes (e.g. incidence/recurrence rate of urinary stones; adverse events) using risk ratios (RRs) with 95% confidence intervals (CIs). We calculated hazard ratio (HRs) and corresponding 95% CIs to assess the intervention effect for time-to-event outcomes. We assessed the certainty of the evidence by using the GRADE criteria.
Our search identified no RCTs investigating the role of increased water intake for the prevention of urinary stone formation in participants with no history of urinary stones (primary prevention). We found one RCT assessing the effects of increased water intake versus standard water intake for the prevention of urinary stone formation in people with a history of urinary stones (secondary prevention). This trial randomised 220 participants (110 participants in the intervention group with increased water intake and 110 in the control group with standard water intake). Increased water intake was defined as achieving a urine volume of at least 2.0 L per day by drinking water. Based on this study, increased water intake may decrease stone recurrences (RR 0.45, 95% CI 0.24 to 0.84; 199 participants; low-certainty evidence); this corresponds to 149 fewer (43 fewer to 205 fewer) stone recurrences per 1000 participants with 270 stone recurrence per 1000 participants over five years in the control group. Increased water intake may also prolong the time to urinary stone recurrence compared to standard water intake (HR 0.40, 95% CI 0.20 to 0.79; 199 participants; low-certainty evidence); based on a stone recurrence rate of 270 per 1000 participants over five years, this corresponds to 152 fewer (209 fewer to 50 fewer) recurrences per 1000 participants. For both outcomes we downgraded the certainty of evidence for study limitations and imprecision. We found no evidence for the outcome of adverse events AUTHORS' CONCLUSIONS: We found no RCT evidence on the role of increased water intake for primary prevention of urinary stones. For secondary prevention, increased water intake achieving a urine volume of at least 2.0 L/day may reduce urinary stone recurrence and prolong time to recurrence for people with a history of urinary stone disease. However, our confidence in these findings is limited. We did not find evidence for adverse events.
尿石症是一种常见疾病,其患病率不断上升且复发率很高。观察性研究报告称,增加饮水量在预防尿石形成中发挥了作用,但证据力度有限。
比较增加饮水量与标准饮水量对有或无尿石病史参与者预防尿石形成的效果。
我们对截至2019年10月15日的PubMed(MEDLINE)、EMBASE(Ovid)和Cochrane图书馆进行了系统检索。我们手工检索了综述文章、临床试验注册库以及检索到文章的参考文献列表。我们对出版语言或出版状态未施加任何限制。
我们纳入了随机对照试验(RCT)和半随机对照试验,这些试验研究了增加饮水量与标准饮水量对有或无尿石病史参与者预防尿石形成的利弊。
我们采用了Cochrane期望的标准方法程序。两位综述作者独立提取数据并评估纳入研究的偏倚风险。我们使用风险比(RR)及95%置信区间(CI)汇总二分结局(如尿石症的发病率/复发率;不良事件)。我们计算风险比(HR)及相应的95%CI以评估干预对事件发生时间结局的效果。我们使用GRADE标准评估证据的确定性。
我们的检索未发现RCT研究增加饮水量对无尿石病史参与者预防尿石形成的作用(一级预防)。我们发现一项RCT评估了增加饮水量与标准饮水量对有尿石病史人群预防尿石形成的效果(二级预防)。该试验将220名参与者随机分组(干预组110名参与者增加饮水量且对照组110名参与者采用标准饮水量)。增加饮水量定义为通过饮水使尿量达到至少每天2.0L。基于这项研究,增加饮水量可能会降低结石复发率(RR 0.45,95%CI 0.24至0.84;199名参与者;低确定性证据);这相当于每1000名参与者中结石复发减少149例(减少43例至减少205例),对照组中每1000名参与者在五年内有270例结石复发。与标准饮水量相比,增加饮水量可能还会延长尿石复发时间(HR 0.40,95%CI 0.20至0.79;199名参与者;低确定性证据);基于每1000名参与者在五年内结石复发率为270例,这相当于每1000名参与者中复发减少152例(减少209例至减少50例)。对于这两个结局,我们因研究局限性和不精确性而降低了证据的确定性。我们未发现不良事件结局的证据。
我们未发现关于增加饮水量对尿石症一级预防作用的RCT证据。对于二级预防,增加饮水量使尿量达到至少每天2.0L可能会降低有尿石症病史人群的尿石复发率并延长复发时间。然而,我们对这些发现的信心有限。我们未发现不良事件的证据。